Breaking News Instant updates and real-time market news.

KHC

Kraft Heinz

$46.34

0.21 (0.46%)

14:05
12/19/18
12/19
14:05
12/19/18
14:05

Kraft Heinz call volume above normal and directionally bullish

Bullish option flow detected in Kraft Heinz with 6,439 calls trading, 1.2x expected, and implied vol increasing almost 2 points to 31.20%. Jan-19 47.5 calls and Jan-19 50 calls are the most active options, with total volume in those strikes near 4,700 contracts. The Put/Call Ratio is 0.30. Earnings are expected on February 15th.

KHC Kraft Heinz
$46.34

0.21 (0.46%)

11/14/18
JPMS
11/14/18
DOWNGRADE
Target $66
JPMS
Neutral
JPMorgan downgrades Kellogg to Neutral, removes from Analyst Focus List
JPMorgan analyst Ken Goldman downgraded Kellogg (K) to Neutral from Overweight and lowered his price target for the shares to $66 from $73. The analyst also removed the stock from his firm's Analyst Focus List. He says that while nothing at the company's investor day "necessarily disappointed" him, he also did not gain "much comfort that the bottom-line turnaround would be swift." Maintaining an Overweight rating in the face of flat EBIT growth in both 2018 and 2019 "requires a bit more patience than we have at the moment," Goldman writes in a note to investors. With that said, the analyst did raise the likelihood that Kellogg gets taken out at a 25% premium to 15% from 5% in his scenario analysis. This is not because of anything specific to Kellogg, but rather because Kraft Heinz (KHC) seems close to buying something in consumer staples, says the analyst. Goldman sees a number of companies are potential targets, including General Mills (GIS), Kellogg, an overseas food producer, or a consumer staples company outside food.
11/07/18
MSCO
11/07/18
NO CHANGE
Target $49
MSCO
Underweight
Kraft Heinz Canadian cheese divestiture a 'small positive,' says Morgan Stanley
Morgan Stanley analyst Dara Mohsenian called Kraft Heinz's agreement to sell its Canadian natural cheese business to Parmalat for $1.23B a "small positive," stating that the deal removes a less attractive business with a lower margin at a reasonable sales multiple. This second announced small scale divestiture in the last two weeks perhaps highlights the need for Kraft Heinz to prioritize debt pay down, said Mohsenian, who continues to believe the company's balance sheet position is an underappreciated risk. He keeps an Underweight rating on Kraft Heinz shares with a $49 price target.
11/05/18
BMOC
11/05/18
NO CHANGE
Target $61
BMOC
Market Perform
Kraft Heinz price target lowered to $61 from $67 at BMO Capital
BMO Capital analyst Kenneth Zaslow lowered his price target on Kraft Heinz to $61 after its Q3 earnings miss, saying the company's "significant operating profit shortfall more than offset better-than-expected top-line growth and a favorable tax rate". The analyst also notes that the management was confident that the company's organic sales growth would persist into Q4 and that its EBITDA growth and margins will recover. Longer term, Zaslow keeps his Market Perform rating on Kraft Heinz based on its "lower EBITDA base and concern that the ongoing transitory issues signify structural and persistent challenge."
11/02/18
JEFF
11/02/18
NO CHANGE
Target $75
JEFF
Buy
Kraft Heinz selloff today a buying opportunity, says Jefferies
Jefferies analyst Akshay Jagdale recommends buying shares of Kraft Heinz on today's post-earnings weakness. The analyst says the quarter delivered on one core pillar of his thesis, which is improvement in organic growth. Kraft Heinz's 2.6% organic growth was the best in at least four years, Jagdale tells investors in a post-earnings research note. However, profitability was much weaker than expected leading to a significant profit miss, says the analyst. He believes the market is viewing this earnings miss as structural while he views it as transitory, "especially in light of the strong sales growth performance and momentum." Jagdale has a Buy rating on Kraft Heinz with a $75 price target. The stock in early trading is down 8%, or $4.40, to $51.80.

TODAY'S FREE FLY STORIES

MTG

MGIC Investment

$13.74

0.22 (1.63%)

06:48
10/22/19
10/22
06:48
10/22/19
06:48
Earnings
MGIC Investment reports Q3 adj. EPS 48c, consensus 42c »

Reports Q3 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Oct

CIT

CIT Group

$45.65

1.36 (3.07%)

06:47
10/22/19
10/22
06:47
10/22/19
06:47
Earnings
CIT Group reports Q3 EPS $1.50, consensus $1.21 »

Reports Q3 revenue $454M,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Oct

GPK

Graphic Packaging

$14.86

0.205 (1.40%)

06:44
10/22/19
10/22
06:44
10/22/19
06:44
Earnings
Graphic Packaging reports Q3 EPS 20c, consensus 19c »

Reports Q3 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Oct

  • 13

    Nov

BIIB

Biogen

$223.57

3.52 (1.60%)

06:44
10/22/19
10/22
06:44
10/22/19
06:44
Hot Stocks
Biogen soars 20% on plans to pursue Alzheimer's approval after FDA talks »

Shares of Biogen are…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Oct

HLX

Helix Energy

$8.32

0.31 (3.87%)

06:43
10/22/19
10/22
06:43
10/22/19
06:43
Earnings
Helix Energy narrows FY19 revenue view to $730M-$760M from $700M-$760M »

Consensus is $749.91M.…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Oct

  • 13

    Nov

  • 14

    Nov

PNTG

The Pennant Group

$18.37

0.19 (1.05%)

06:43
10/22/19
10/22
06:43
10/22/19
06:43
Initiation
The Pennant Group initiated  »

The Pennant Group…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

PEBO

Peoples Bancorp

$32.28

0.57 (1.80%)

06:42
10/22/19
10/22
06:42
10/22/19
06:42
Earnings
Peoples Bancorp reports Q3 EPS 72c, consensus 70c »

Reports Q3 book value per…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Oct

  • 13

    Nov

  • 04

    Dec

  • 05

    Dec

ACRS

Aclaris Therapeutics

$1.40

-0.205 (-12.77%)

06:41
10/22/19
10/22
06:41
10/22/19
06:41
Upgrade
Aclaris Therapeutics rating change  »

Aclaris Therapeutics…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 28

    Oct

FITB

Fifth Third

$28.04

0.71 (2.60%)

06:40
10/22/19
10/22
06:40
10/22/19
06:40
Hot Stocks
Fifth Third sees Q4 NII down about 1% from Q3, NIM down 4-5bps »

Sees FY19 NII up about…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Oct

  • 29

    Oct

ARCH

Arch Coal

$78.98

-0.1 (-0.13%)

06:39
10/22/19
10/22
06:39
10/22/19
06:39
Hot Stocks
Arch Coal backs FY19 total sales volume view 86.7- 92.1 tons »

"We are confident in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Oct

HAS

Hasbro

$120.11

-1.78 (-1.46%)

06:39
10/22/19
10/22
06:39
10/22/19
06:39
Hot Stocks
Hasbro CEO says 'on track to deliver profitable revenue growth in 2019' »

"Hasbro remains on…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Oct

  • 22

    Oct

  • 23

    Oct

  • 24

    Oct

  • 25

    Oct

CVNA

Carvana

$77.23

3.42 (4.63%)

06:39
10/22/19
10/22
06:39
10/22/19
06:39
Recommendations
Carvana analyst commentary  »

Carvana sold 15,239…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 06

    Nov

ARCH

Arch Coal

$78.98

-0.1 (-0.13%)

06:37
10/22/19
10/22
06:37
10/22/19
06:37
Earnings
Arch Coal reports Q3 EPS $6.34, consensus $3.39 »

Reports Q3 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Oct

ARES

Ares Management

$28.28

0.42 (1.51%)

, NEP

NextEra Energy Partners

$51.04

-0.54 (-1.05%)

06:37
10/22/19
10/22
06:37
10/22/19
06:37
Hot Stocks
Ares Management sells ownership in Meade Pipeline to NextEra Energy Partners »

Ares Management (ARES)…

ARES

Ares Management

$28.28

0.42 (1.51%)

NEP

NextEra Energy Partners

$51.04

-0.54 (-1.05%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Oct

  • 31

    Oct

  • 04

    Dec

KOOL

Cesca Therapeutics

$5.31

-0.14 (-2.57%)

06:37
10/22/19
10/22
06:37
10/22/19
06:37
Hot Stocks
Cesca Therapeutics forms JV with Healthbanks Biotech »

Cesca Therapeutics and…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

BIIB

Biogen

$223.57

3.52 (1.60%)

06:36
10/22/19
10/22
06:36
10/22/19
06:36
Hot Stocks
Breaking Hot Stocks news story on Biogen »

Biogen to offer access to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Oct

BIIB

Biogen

$223.57

3.52 (1.60%)

06:36
10/22/19
10/22
06:36
10/22/19
06:36
Hot Stocks
Breaking Hot Stocks news story on Biogen »

Biogen: Analysis of…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Oct

SNV

Synovus

$36.30

1.005 (2.85%)

06:35
10/22/19
10/22
06:35
10/22/19
06:35
Earnings
Synovus reports Q3 adjusted EPS 97c, consensus 99c »

Reports Q3 provision for…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Oct

  • 13

    Nov

BIIB

Biogen

$223.57

3.52 (1.60%)

, ESALY

Eisai

$0.00

(0.00%)

06:35
10/22/19
10/22
06:35
10/22/19
06:35
Hot Stocks
Biogen plans aducanumab BLA in early 2020 based on FDA talks »

Biogen (BIIB) and Eisai…

BIIB

Biogen

$223.57

3.52 (1.60%)

ESALY

Eisai

$0.00

(0.00%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Oct

FBC

Flagstar Bancorp

$38.72

0.39 (1.02%)

06:34
10/22/19
10/22
06:34
10/22/19
06:34
Earnings
Flagstar Bancorp reports Q3 EPS $1.11, consensus $1.04 »

Reports Q3 book value per…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Oct

  • 13

    Nov

BIIB

Biogen

$223.57

3.52 (1.60%)

, ESALY

Eisai

$0.00

(0.00%)

06:34
10/22/19
10/22
06:34
10/22/19
06:34
Hot Stocks
Breaking Hot Stocks news story on Biogen, Eisai »

Biogen plans aducanumab…

BIIB

Biogen

$223.57

3.52 (1.60%)

ESALY

Eisai

$0.00

(0.00%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Oct

UBS

UBS

$11.53

0.18 (1.59%)

06:33
10/22/19
10/22
06:33
10/22/19
06:33
Periodicals
UBS to address client overcharges in Singapore, Hong Kong, Reuters reports »

UBS is working with…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Oct

  • 12

    Nov

FITB

Fifth Third

$28.04

0.71 (2.60%)

06:33
10/22/19
10/22
06:33
10/22/19
06:33
Earnings
Fifth Third reports Q3 EPS 71c with items, consensus 73c »

Reported results included…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Oct

  • 29

    Oct

VRTX

Vertex

$183.73

7.49 (4.25%)

06:32
10/22/19
10/22
06:32
10/22/19
06:32
Recommendations
Vertex analyst commentary  »

Vertex price target…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 30

    Oct

  • 19

    Mar

PHM

PulteGroup

$38.24

-0.08 (-0.21%)

06:32
10/22/19
10/22
06:32
10/22/19
06:32
Hot Stocks
PulteGroup reports Q3 unit backlog up 4% to 11,638 Homes »

Reports Q3 backlog value…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Oct

  • 06

    Nov

  • 07

    Nov

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.